Grassley Comment on SEC Chairman Response on Pequot Investigation, Enforcement Problems

Sen. Chuck Grassley today made the following comment on a response from Securities and Exchange Commission Chairman Mary Schapiro in response to his inquiry on enforcement concerns. “For years, I’ve urged the SEC to change its culture and step up enforcement. If it’s turning the corner culturally, better automated systems to show patterns of potential […]

Notification from Treasury of dropping request to Justice Department on SIGTARP

The text of the letter follows: Dear Senators Baucus and Grassley, This is to confirm that the enclosed message from Treasury’s Acting General Counsel Bernard Knight to David Barron, Acting Assistan Attorney General at the Ofice of Legal Counsel, and Daniel Koffsky, Deputy Assistant Attorney General at the Office of Legal Counsel, was sent to […]

Baucus, Grassley Introduce Bill to Strengthen Customs Facilitation, Enforcement

Washington, D.C. – Senate Finance Committee Chairman Max Baucus (D-Mont.) and Ranking Member Chuck Grassley (R-IA) today introduced legislation to strengthen customs facilitation and trade enforcement efforts within the Department of Homeland Security’s U.S. Customs and Border Protection (CBP) and U.S. Immigration and Customs Enforcement (ICE). The Customs Facilitation and Trade Enforcement Reauthorization Act of […]

House Democrats’ Surtax Will Worsen Long-term Debt, Economic Prospects

Mr. President, we’re only nine months into fiscal year 2009, and for the first time in American history, the federal deficit has reached and exceeded $1 trillion. This is not one of those “firsts” for our great nation that calls for celebration. Unfortunately, the bad fiscal news is not yet over for the year. We […]

Grassley works for transparency in financial ties between doctors and industry

WASHINGTON — Senator Chuck Grassley is asking the National Navy Medical Center for information about its policies and practices requiring military doctors to report income from the pharmaceutical, medical device and biologics industries. Grassley said the inquiry is part of his ongoing effort to disclose these relationships to enhance transparency and, in turn, build public […]